Key result
Whole-body FDG PET/CT detects multiple metastatic sites in a scalp epithelioid angiosarcoma case.
Why the study?
Does FDG PET/CT detect metastatic sites in a patient with epithelioid angiosarcoma of the scalp?
Case Report (n=1)
Does FDG PET/CT detect metastatic sites in a patient with epithelioid angiosarcoma of the scalp?
FDG PET/CT is clinically useful for the early detection of metastases in rare cases of epithelioid angiosarcoma.
May aid metastasis detection in epithelioid angiosarcoma; hypothesis-generating, needs prospective validation before practice change.
Epithelioid angiosarcoma is a rare subtype of angiosarcoma, with metastases occurring in more than 50% of cases and the lung is the most organ which is involved. Whole-body fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has demonstrated its clinical utility in the early detection of metastases in angiosarcoma. It is helpful to differentiate between benign lesions with low FDG uptake as compared to malignancies with high FDG avidity. Here, we present a rare case of a young man with epithelioid angiosarcoma, in which FDG PET/CT has demonstrated metastatic sites (especially lung metastases).
No takes yet. Share an insight, caveat, or question.
Purandare et al. (2023) conducted a case report in Epithelioid angiosarcoma of the scalp (n=1). FDG PET/CT was evaluated on Detection of metastatic sites. Whole-body FDG PET/CT successfully demonstrated multiple metastatic sites, especially lung metastases, in a young man with epithelioid angiosarcoma of the scalp.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: